Control shRNA tumors showed only ~10% reduction in tumor volume in response to B20 (Fig 6H and 6I) whereas suppression of Foxc2 drastically flattened tumor growth curves upon B20 treatment (Fig 6H), reducing tumor volume ~70% relative to vehicle (Fig 6H and 6I). This evidence concerns the gene FOXC2 and neoplasm.